Ori Elkayam Sign in to save

ORCID 0000-0001-9329-3639 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (8)

3× Tel Aviv University, Rheumatology, Tel Aviv, Israel
2× Rheumatology
1× Rheumatology, Tel Aviv Medical Center, Tel Aviv, Israel
1× Tel Aviv Medical Center
1× Rheumatology, Tel Aviv University, Tel Aviv, Israel
1× Tel Aviv University
1× Tel Aviv University *
1× Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Department of Rheumatology, Tel Aviv, Israel

Papers 6 stored

All · Aachen affiliation only

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)
2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

27

citations
OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)
2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

6

citations
OP0266 TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS AS AN OVERALL MEASURE OF TOLERANCE AND SAFETY OF JAK-INHIBITORS: AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-pot” STUDY).
2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access

0

citations
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
2022 Annals of the Rheumatic Diseases article Medicine COVID-19 Clinical Research Studies Open access

166

citations
POS0093 HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)
2021 Annals of the Rheumatic Diseases conference-abstract Pharmacology, Toxicology and Pharmaceutics Pharmacovigilance and Adverse Drug Reactions Open access

0

citations
OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)
2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

31

citations

6 results

Ori Elkayam ▲ Sign in to save

Departments & institutes in Aachen

Papers 6 stored

Ori Elkayam Sign in to save